Avelumab plus axitinib vs. sunitinib for advanced renal-cell carcinoma.

ABSTRACT:

SUBMITTER: Zhang Y 

PROVIDER: S-EPMC8798318 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature